Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLTG.L Regulatory News (BLTG)

  • There is currently no data for BLTG

Contract win

17 Aug 2010 08:00

RNS Number : 1594R
Regenersis PLC
17 August 2010
 



17 August 2010

 

Regenersis plc

 

("Regenersis" or the "Group")

 

LG selects Regenersis for major customer care centre solution

 

 

Regenersis (LSE:RGS) has been selected by LG UK to deliver a ground-breaking customer care centre deal in the UK. Regenersis will deliver a 50-seat customer care centre dedicated to LG from its Huntingdon (Cambridgeshire) facility.

 

The care centre will handle a wide range of support functions for LG customers - from general enquiries through to high-level technical support. Providing phone, email, white-mail and web chat solutions, the facility will be a centre of excellence for a wide range of LG products - from home appliances to flat panel televisions, computers and monitors, to home cinema and mobiles. It is anticipated that the care centre will handle more than half a million service events per year.

 

Gary Stokes, CEO of Regenersis said, "The solution we are delivering to LG demonstrates the breadth and depth of our service offering. Our strategy to focus on delivering total solutions in the after-sales market is yielding significant results. This is an ideal example of a leading brand looking for a trusted partner who understands the importance of delivering a strong, customer focused after-sales infrastructure."

 

Pat Doughty, Service Director of LG UK said, "After a thorough evaluation, we selected Regenersis over the more typical call centre providers because they understood the total cost of after-sales and could deliver not only the high quality of service we required, but an excellent understanding of our requirement to deliver the best customer experience all underpinned by a high level of integrated technical expertise."

 

-Ends-

 

For further information please contact:

 

Regenersis plc +44 (0)7789 435 100

Sarah Bond (sarah.bond@regenersis.com)

Arden Partners plc

Steve Douglas +44 (0) 121 423 8900

 

Financial Dynamics +44 (0)20 7831 3113

Matt Dixon / Nicola Biles / Charles Palmer

 

 

About Regenersis (www.regenersis.com)

Regenersis (LSE: RGS) is a leading provider of after sales product support services to many of the World's premier technology brands. If a product fails we will fix it, if the product is no longer in use we will find a new market for it and if it is beyond use we will recycle it safely and responsibly. The Company is listed on the Alternative Investment Market (AIM) of the London Stock Exchange, has operations across Europe and Asia, and generates annual revenues of approximately £100m.

 

About LG (www.LG.com)

LG Electronics, Inc. (KSE: 066570.KS) is a global leader and technology innovator in consumer electronics, mobile communications and home appliances, employing more than 80,000 people working in over 115 operations around the world. With 2009 global sales of 55.5 trillion Korean Won (43.4 billion US Dollars), LG comprises of five business units - Home Entertainment, Mobile Communications, Home Appliance, Air Conditioning and Business Solutions. LG is one of the world's leading producers of flat panel TVs, audio and video products, mobile handsets, air conditioners and washing machines. LG has signed a long-term agreement to become both a Global Partner of Formula 1™ and a Technology Partner of Formula 1™. As part of this top-level association, LG acquires exclusive designations and marketing rights as the official consumer electronics, mobile phone and data processor of this global sporting event.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABLGDIBDBBGGL
Date   Source Headline
4th Oct 20185:41 pmRNSHolding(s) in Company
25th Sep 20187:00 amRNSFinal Results
27th Jul 20189:14 amRNSHolding(s) in Company
26th Jul 201811:00 amRNSDirector/PDMR Shareholding
11th Jul 20187:00 amRNSAppointment of Chief Financial Officer
11th Jul 20187:00 amRNSTrading Update and Notice of Results
29th Jun 20188:59 amRNSHolding(s) in Company
13th Jun 201812:16 pmRNSHolding(s) in Company
12th Jun 201812:28 pmRNSHolding(s) in Company
18th Apr 20182:40 pmRNSHolding(s) in Company
18th Apr 201812:05 pmRNSHolding(s) in Company
29th Mar 201811:40 amRNSDirector/PDMR Shareholding
28th Mar 20187:00 amRNSAppointment of Chief Executive Officer
26th Mar 201812:04 pmRNSHolding(s) in Company
22nd Mar 20182:27 pmRNSHolding(s) in Company
20th Mar 20187:11 amRNSHalf-year Report
9th Feb 201812:31 pmRNSDirector/PDMR Shareholding
19th Jan 201810:27 amRNSHolding(s) in Company
19th Jan 20187:00 amRNSTrading Update and Notice of Results
19th Dec 20175:35 pmRNSResult of AGM
24th Nov 20172:48 pmRNSPosting of Annual Report & Notice of AGM
8th Nov 20172:05 pmRNSSecond Price Monitoring Extn
8th Nov 20172:00 pmRNSPrice Monitoring Extension
7th Nov 20177:00 amRNSFinal Results
6th Nov 201710:25 amRNSHolding(s) in Company
3rd Nov 20175:03 pmRNSNotice of Results
13th Oct 20171:01 pmRNSHolding(s) in Company
2nd Oct 20177:00 amRNSPreparation of preliminary results
27th Sep 20173:58 pmRNSHolding(s) in Company
20th Sep 20175:54 pmRNSHolding(s) in Company
7th Sep 20177:00 amRNSBoard Update
4th Sep 20177:00 amRNSUpdates on revenue and management
3rd Aug 201712:37 pmRNSHolding(s) in Company
11th Jul 20173:33 pmRNSHolding(s) in Company
6th Jul 20177:00 amRNSTrading Statement
6th Jun 20173:16 pmRNSHolding(s) in Company
30th May 20177:00 amRNSDirectorate Change
16th May 20177:00 amRNSUpdate on Ordinary Shares
12th May 20173:53 pmRNSHolding(s) in Company
10th May 20173:34 pmRNSDirector/PDMR Shareholding
9th May 201712:27 pmRNSDirector/PDMR Shareholding
9th May 201712:26 pmRNSHolding(s) in Company
4th May 20177:00 amRNSResult of Placing
3rd May 20175:04 pmRNSProposed Placing
26th Apr 20176:01 pmRNSHolding(s) in Company
25th Apr 20177:00 amRNSQ3 Trading Update, Cash Flow Review and Funding
15th Mar 20172:55 pmRNSHolding(s) in Company
15th Mar 201711:27 amRNSDirector/PDMR Shareholding
15th Mar 20177:00 amRNSDirector/PDMR Shareholding
14th Mar 20172:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.